FDA seeks closer work with India’s regulator after visit

The chief of the US drug regulator is travelling to India this week to "strengthen cooperation" with India's pharmaceutical regulator.

The FDA's commissioner, Margaret Hamburg, will talk to industry as well as to the government. A statement said US-India cooperation was wide-ranging, from "sharing information on the conduct of clinical trials to jointly addressing product safety issues that may have an impact on both American and Indian consumers".

"The FDA's ongoing engagement with our regulatory counterparts in India is critical to our ability to effectively promote the health and safety of American and Indian consumers.

"I look forward to enhancing our existing relationship and identifying additional opportunities for collaboration."

Margaret Hamburg, commissioner, FDA.